eli lilly glp-1 drugs Novo, weight-loss should be first option obesity treatments, European doctors say GLP-1 weight loss could soon
Description
As a result of these findings, the collaborators suggested 'proglucagon 78-107 may be the incretin of the lower gut' (Holst, rskov, Vagn Nielsen, Schwartz)
In a recent study, researchers found that most users regain two-thirds of the weight they lost within 6 to 12 months after stopping the drug
The Role of GLP-1 and GLP-1 Agonist in Type 2 Diabetes
10.1007/s00125-015-3625-5
Scope of review In this review, we provide a detailed overview on the multifaceted nature of GLP-1 and its pharmacology and discuss its therapeutic implications on various diseases
